TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the

TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the

https://www.sec.gov/Archives/edgar/data/1638097/000117891326004221/zk2635989.htm

Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development

Entera Bio NASDAQ: ENTX plans to begin a Phase 3 study of its oral osteoporosis candidate EB613 afte

IND Enabling Studies Ongoing for EB612 - the First Oral Peptide Replacement Tablet in Development fo

U.S. Food and Drug Administration (FDA) Alignment on 12-Month Registrational Phase 3 Study to Suppor

Two presentations including the Plenary Poster Presentation at the American Society for Bone and Min

TEL AVIV, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company

TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company

MIAMI, July 29, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Entera Bio Ltd.

Entera Bio Ltd. (NASDAQ:ENTX) shares traded higher Wednesday after the company announced an oversubs

Entera Bio financing lifts ENTX as investors weigh a $275 million cash boost, EB613 funding and dilu

Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular

US stocks mixed in midday trading, Nasdaq falls 0.48%, Dow up 0.19%, S&P 500 down 0.23%. Consume

Dow Jones up 0.80% to 52,361.92, NASDAQ up 0.23% to 25,024.65, S&P 500 up 0.28% to 7,432.59. Com

Expected gross proceeds are anticipated to extend the Company's cash runway into 2030 and fully

The offering is led by existing investor BVF Partners L.P. Expected gross proceeds are anticipated t

ENTX stock jumps 35% in a month after the FDA backs a streamlined phase III plan for oral osteoporos

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

Entera Bio (NASDAQ:ENTX) may have just cleared its biggest regulatory hurdle yet. The FDA has provid

Entera Bio (NASDAQ: ENTX) may have just cleared its biggest regulatory hurdle yet. The FDA has provi

Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi

Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market

Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the developm

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primar

EB612, a first-in-class long-acting PTH(1-34) oral peptide  for hypoparathyroidism, produced robust

EB612, a first-in-class long-acting PTH(1-34) oral peptide  for hypoparathyroidism, produced robust

Entera Bio Ltd. (NASDAQ:ENTX) ("Entera" or the "Company"), a leader in the developme

The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB61

Abstract Title: Transforming Anabolic Treatments for Osteoporosis: New Clinical Data Supports a Sing

TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.07) per share which beat the analyst conse

EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteopor

Entera Bio (ENTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

Entera Bio Ltd. (ENTX) Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Or

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto

U.S. stock futures up, focus on quarterly earnings of Americas Gold and Silver, ARKO Petroleum, Ente

This is the third program that successfully combines Entera's oral peptide N-Tab® platform with

OPKO Health, Inc. (NASDAQ:OPK) and Entera Bio Ltd. (NASDAQ:ENTX) ("Entera") today announced

The Dow Jones index closed slightly higher on Thursday. When insiders purchase or sell shares, it in

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ

Gainers

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday afte

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $